Title : Abemaciclib: The First FDA-Approved CDK4/6 Inhibitor for the Adjuvant Treatment of HR+ HER2- Early Breast Cancer.

Pub. Date : 2022 Feb 8

PMID : 35135362






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Abemaciclib: The First FDA-Approved CDK4/6 Inhibitor for the Adjuvant Treatment of HR+ HER2- Early Breast Cancer. abemaciclib cyclin dependent kinase 4 Homo sapiens